Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease [PDF]
Recent clinical data with three therapeutic anti-Aβ antibodies have demonstrated that removal of Aβ-amyloid plaques in early Alzheimer's disease (AD) can attenuate disease progression.
Gunnar Nordvall +6 more
doaj +2 more sources
Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. [PDF]
The presenilin/gamma-secretase complex, an unusual intramembrane aspartyl protease, plays an essential role in cellular signaling and membrane protein turnover.
Matthew L Hemming +3 more
doaj +4 more sources
Inhibition of gamma-secretase activity without interfering in Notch signalling decreases inflammatory response in patients with cutaneous leishmaniasis [PDF]
Cutaneous leishmaniasis (CL) patients present an exacerbated inflammatory response associated with tissue damage and ulcer development. Increasing numbers of patients have exhibited treatment failure, which remains not well understood.
Maurício T. Nascimento +8 more
doaj +2 more sources
Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult Cases [PDF]
Desmoid tumors (aggressive fibromatosis) are soft tissue mesenchymal tumors that can be locally invasive and life-threatening. Depending on the location, these tumors are often unresectable or tend to recur after surgery.
David Chan +3 more
doaj +2 more sources
Sustained notch signaling inhibition with a gamma-secretase inhibitor prevents traumatic heterotopic ossification [PDF]
Background: Traumatic heterotopic ossification (THO) is a devastating sequela following traumatic injuries and orthopedic surgeries. To date, the exact molecular mechanism of THO formation is still unclear, which hinders the development of effective ...
Zheng Wang +6 more
doaj +2 more sources
Identification of presenilin mutations that have sufficient gamma-secretase proteolytic activity to mediate Notch signaling but disrupt organelle and neuronal health [PDF]
Mutations that cause familial Alzheimer's disease (AD) are predominantly found in the presenilin (PSEN) encoding genes PSEN1 and PSEN2. While the association of PSEN mutations with familial AD have been known for over 20 years, the mechanism underlying ...
Zahra Ashkavand +5 more
doaj +2 more sources
PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia [PDF]
Background T cell acute lymphoblastic leukemia (T-ALL) is a high-risk subtype that comprises 10–15% of childhood and 20–25% of adult ALL cases. Over 70% of T-ALL patients harbor activating mutations in the NOTCH1 signaling pathway and are predicted to be
Inge Govaerts +11 more
doaj +2 more sources
Inhibition of Gamma-Secretase Promotes Axon Regeneration After a Complete Spinal Cord Injury [PDF]
In a recent study, we showed that GABA and baclofen (a GABAB receptor agonist) inhibit caspase activation and promote axon regeneration in descending neurons of the sea lamprey brainstem after a complete spinal cord injury (Romaus-Sanjurjo et al., 2018a).
Daniel Sobrido-Cameán +6 more
doaj +2 more sources
Synaptic and endosomal localization of active gamma-secretase in rat brain. [PDF]
A key player in the development of Alzheimer's disease (AD) is the gamma-secretase complex consisting of at least four components: presenilin, nicastrin, Aph-1 and Pen-2.
Susanne Frykman +7 more
doaj +1 more source
Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease. [PDF]
Alzheimer disease (AD) is an age-related disorder. Aging and female gender are two important risk factors associated with sporadic AD. However, the mechanism by which aging and gender contribute to the pathogenesis of sporadic AD is unclear.
Lisa Placanica, Lei Zhu, Yue-Ming Li
doaj +1 more source

